Journal of Patient-Reported Outcomes

Table 6 Spearman correlations between scales in the QLQ-C30 and QLQ-NMIBC24 for 541 NMIBC patients participating in UroLife (divergent validity)

From: Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer

QLQ-C30 scales	QLQ-NMIBC24 scales
QLQ-C30 scales	Urinary symptoms (–)^a	Malaise (–)^a	Future worries (–)^a	Bloating and flatulence (–)^a	Sexual function (+)^a	Male sexual problems (–)^a
Physical function (+)^a	− 0.23	− 0.16	− 0.11	− 0.13	0.24	− 0.18
Role function (+)^a	− 0.33	− 0.27	− 0.22	− 0.23	0.14	− 0.14
Emotional function (+)^a	− 0.25	− 0.24	− 0.57	− 0.26	0.10	− 0.12
Cognitive function (+)^a	− 0.15	− 0.20	− 0.21	− 0.24	0.07	− 0.17
Social function (+)^a	− 0.31	− 0.26	− 0.32	− 0.25	0.12	− 0.14
Global Quality of Life (+)^a	− 0.38	− 0.33	− 0.37	− 0.25	0.16	− 0.16
Pain (–)^a	0.35	0.27	0.31	0.25	− 0.13	0.15
Fatigue (–)^a	0.26	0.28	0.27	0.26	− 0.15	0.12
Nausea and vomiting (–)^a	0.14	0.36	0.10	0.17	− 0.03	0.03

^aThe signs (–) and (+) indicate whether higher scores on this scale are worse or better, respectively

Back to article page